New Horizon Health Limited (HK:6606) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
New Horizon Health Limited, a biotech firm specializing in cancer screening products in China, reports that its business operations remain stable despite the ongoing suspension of its stock trading. The company continues to work towards resuming trading, following guidance from the Hong Kong Stock Exchange. Investors are advised to stay informed as the company makes further announcements on its progress.
For further insights into HK:6606 stock, check out TipRanks’ Stock Analysis page.